• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.65% Nasdaq Down 1.89%

    ImmunoCellular Therapeutics, Ltd. (IMUC)

    -NYSE MKT
    0.70 Jan 27, 4:00PM EST
    Add to Portfolio
    Prev Close:0.70
    Open:N/A
    Bid:0.69 x 300
    Ask:0.76 x 1500
    1y Target Est:3.50
    Beta:1.56
    Earnings Date:Mar 11 - Mar 16 (Est.)
    Day's Range:N/A - N/A
    52wk Range:0.53 - 1.52
    Volume:0
    Avg Vol (3m):499,137
    Market Cap:43.90M
    P/E (ttm):N/A
    EPS (ttm):-0.12
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMUC

    Comparison

    Symbol% ChgMkt Cap
    IMUC 0.00%43.90M
    AGEN329.72M
    DNDNN/A
    STML184.67M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.17
    Quarterly EPS Est (Dec-14) :-0.05
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of brain and ovarian cancers. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback